Reno, a European postmarket surveillance registry, confirms effectiveness of coronary brachytherapy in routine clinical practice

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 4, 2003, Pages 1019-1026

  Coen, V ^c   Serruys, P ^d   Sauerwein, W ^d   Orecchia, R ^a   Von Rottkay, P ^d   Coucke, P ^b   Ehnert, M ^d   Urban, P ^d   Bonan, R ^d   Levendag, P ^d  

^a Department of Medicine   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d NONE

Author keywords

Coronary; Radiation; RENO; Restenosis

Indexed keywords

ANGIOCARDIOGRAPHY; BLOOD VESSELS; GRAFTS; PATIENT TREATMENT;

CORONARY BRACHYTHERAPY;

BIOLOGICAL RADIATION EFFECTS;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BETA RADIATION; BRACHYTHERAPY; BYPASS SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; EUROPE; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REGISTER; RESTENOSIS; STENT; THROMBOSIS; TIME;

EID: 0242418188     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04286-4     Document Type: Article

References (27)

1. Forrester J.S., Fishbein M., Helfant R., et al. A paradigm for restenosis based on cell biology Clues for the development of new preventive therapies. J Am Coll Cardiol. 17:1991;758-769.
2. Gruentzig A.R., King S.B., Schlumpf M., et al. Long-term follow-up after percutaneous transluminal coronary angioplasty The early Zurich experience. N Engl J Med. 316:1987;1127-1132.
3. Nobuyoshi M., Kimura T., Nosaka H., et al. Restenosis after successful percutaneous transluminal coronary angioplasty Serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 12:1988;616-623.
4. Holmes D.R., Vliestra R.E., Smith H.C., et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA) A report from the PTCA Registry of the National Heart, Lung and Blood Institute. Am J Cardiol. 53:1984;77C-81C.
5. Serruys P.W., De Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
6. Kuntz R.E., Gibson C.M., Nobuyoshi M., et al. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol. 21:1993;15-25.
7. Teirstein P.S., Massullo V., Jani S.K., et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med. 336:1997;1697-1703.
8. King S.B., Williams D.O., Chougule P., et al. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty Results of the beta energy restenosis trial (BERT). Circulation. 97:1998;2025-2030.
9. Teirstein P.S., Massullo V., Jani S.K., et al. Three-year clinical, and angiographic follow-up after intracoronary radiation Results of a randomized clinical trial. Circulation. 101:2000;360-365.
10. Waksman R., Bhargava B., White L.R., et al. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation. 101:2000;1895-1898.
11. Raizner A.E., Oesterle S.N., Waksman R., et al. Inhibition of restenosis with beta-emitting radiotherapy Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation. 102:2000;951-958.
12. Waksman R., White L.R., Chan R.C., et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation. 101:2000;2165-2171.
13. Leon M.B., Teirstein P.S., Moses J.W., et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 344:2001;250-256.
14. Sabate M. Geographical miss A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation. 101:2000;2467-2471.
15. Kleiman N.S., Califf R.M. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. J Am Coll Cardiol. 36:2000;310-325.
16. Waksman R., Raizner A.E., Yeung A.C., et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis The INHIBIT randomised controlled trial. Lancet. 9306:2002;551-557.
17. Waksman R., Ajani A.E., White L.R., et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med. 346:2002;1194-1199.
18. Giap H.B., Bendre D.D., Huppe G.B., et al. Source displacement during the cardiac cycle in coronary endovascular brachytherapy. Int J Radiat Oncol Biol Phys. 49:2001;273-277.
19. Potter R., Van Limbergen E., Dries W., et al. Recommendations of the EVA GEC ESTRO Working Group Prescribing, recording, and reporting in endovascular brachytherapy - Quality assurance, equipment, personnel and education. Radiother Oncol. 59:2001;339-360.
20. Suntharalingam M., Laskey W., Lansky A.J., et al. Clinical and angiographic outcomes after use of strontium-90/yttrium-90 beta radiation for the treatment of in-stent restenosis Results from the stents and radiation therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys. 52:2002;1075-1082.
21. Coen V.L.M.A., Marijnissen J.P.A., Ligthart J.M.R., et al. Inaccuracy in manual multisegmental irradiation in coronary arteries. Radiother Oncol. 63:2002;89-95.
22. Verin V., Popowski Y., De Bruyne B., et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med. 344:2001;243-249.
23. Li X.A., Wang R., Yu C., et al. Beta versus gamma for catheter-based intravascular brachytherapy Dosimetric perspectives in the presence of metallic stents and calcified plaques. Int J Radiat Oncol Biol Phys. 46:2000;1043-1049.
24. Ye S.J., Li X.A., Zimmer J.R., et al. Dosimetric perturbations of linear array of beta-emitter seeds and metallic stent in intravascular brachytherapy. Med Phys. 27:2000;374-380.
25. Amols H., Trichter F., Weinberger J. Intracoronary radiation for prevention of restenosis Dose perturbations caused by stents. Circulation. 98:2001;2024-2029.
26. Nath R., Yue N., Weinberger J. Dose perturbations by high atomic number materials in intravascular brachytherapy. Cardiovasc Radiat Med. 1:1999;144-153.
27. Waksman R., Bhargava B., Mintz G.S., et al. Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis. J Am Coll Cardiol. 36:2000;65-68.